RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
27 hedge funds and large institutions have $11.1M invested in Regulus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $13.8M → $11.1M (-$2.72M)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
27
Holding in Top 10
–
Calls
$956K
Puts
$2K
Top Buyers
| 1 | +$66.8K | |
| 2 | +$10.5K | |
| 3 | +$4.27K | |
| 4 |
Renaissance Technologies
New York
|
+$3.77K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$473 |
Top Sellers
| 1 | -$38K | |
| 2 | -$25.2K | |
| 3 | -$11.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.1K |
| 5 |
BlackRock
New York
|
-$1.45K |